Tags

Type your tag names separated by a space and hit enter

The role of nonsteroidal anti-inflammatory drugs in the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis.
JOP. 2014 May 27; 15(3):219-24.JOP

Abstract

Post-ERCP pancreatitis (PEP) is the most common major complication associated with ERCP. Beginning with an overview of the risk factors for the development of PEP, this review introduces the mechanism of injury in PEP and the role of pharmacological prevention. NSAIDs are increasingly found to offer prevention against the development of PEP, and their mechanism and supportive data are summarized, especially in relationship to the practice of prophylactic pancreatic duct stenting.

Authors+Show Affiliations

Division of Gastroenterology, University of Tennessee Health Science Center, Memphis, TN, USA. isheik@uthsc.edu.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

24865531

Citation

Sheikh, Imran, et al. "The Role of Nonsteroidal Anti-inflammatory Drugs in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis." JOP : Journal of the Pancreas, vol. 15, no. 3, 2014, pp. 219-24.
Sheikh I, Fontenot E, Waghray N, et al. The role of nonsteroidal anti-inflammatory drugs in the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis. JOP. 2014;15(3):219-24.
Sheikh, I., Fontenot, E., Waghray, N., Ismail, M. K., Tombazzi, C., & Smith, J. L. (2014). The role of nonsteroidal anti-inflammatory drugs in the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis. JOP : Journal of the Pancreas, 15(3), 219-24. https://doi.org/10.6092/1590-8577/2258
Sheikh I, et al. The Role of Nonsteroidal Anti-inflammatory Drugs in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis. JOP. 2014 May 27;15(3):219-24. PubMed PMID: 24865531.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The role of nonsteroidal anti-inflammatory drugs in the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis. AU - Sheikh,Imran, AU - Fontenot,Eric, AU - Waghray,Nisheet, AU - Ismail,Mohammad K, AU - Tombazzi,Claudio, AU - Smith,J Lacey, Y1 - 2014/05/27/ PY - 2014/01/21/received PY - 2014/03/26/accepted PY - 2014/03/24/revised PY - 2014/5/29/entrez PY - 2014/5/29/pubmed PY - 2015/1/13/medline SP - 219 EP - 24 JF - JOP : Journal of the pancreas JO - JOP VL - 15 IS - 3 N2 - Post-ERCP pancreatitis (PEP) is the most common major complication associated with ERCP. Beginning with an overview of the risk factors for the development of PEP, this review introduces the mechanism of injury in PEP and the role of pharmacological prevention. NSAIDs are increasingly found to offer prevention against the development of PEP, and their mechanism and supportive data are summarized, especially in relationship to the practice of prophylactic pancreatic duct stenting. SN - 1590-8577 UR - https://www.unboundmedicine.com/medline/citation/24865531/The_role_of_nonsteroidal_anti_inflammatory_drugs_in_the_prevention_of_post_endoscopic_retrograde_cholangiopancreatography_pancreatitis_ L2 - http://www.serena.unina.it/index.php/jop/article/view/2258/2468 DB - PRIME DP - Unbound Medicine ER -